Enhancement of glutathione levels with glutamine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31195

Patent

active

052486974

ABSTRACT:
A method of maintaining and/or enhancing tissue or plasma levels of glutathione is provided. Treatment of a mammal with a supranormal amount of glutamine, or a glutamine equivalent, prevents the reduction in tissue glutathione levels associated with exposure of the mammal to a compound capable of oxidative injury to the tissue. Such compounds may be drugs such as chemotherapeutic agents. Administration of a supranormal amount of glutamine or a glutamine equivalent after exposure of a mammal to a compound capable of oxidative injury to the tissue can ameliorate or prevent injury. Treatment of a mammal with glutamine or a glutamine equivalent can also reduce or prevent starvation- or radiation-associated oxidative damage in the tissues.

REFERENCES:
patent: 4438124 (1984-03-01), Meister et al.
patent: 4439448 (1984-03-01), Munakata et al.
Chemical Abstracts 96:210715v (1982).
Chemical Abstracts 100:180128n (1984).
Welbourne et al., Life Sciences 30:793-801 (1982).
Yamada, Jap. J. Anesth. 26:640-645 (1977).
Zimmerman et al., J. Immunol. 142(4):1405-1409 (1989).
Anderson et al., Arch. Biochem. Biophys. 239(2):538-548 (1985).
Babson et al., Biochem Pharmacol. 30(16):2299-2304 (1981).
Beck et al., Proc. Soc. Expt. Biol. 86:823-827 (1954).
Beck et al., Proc. Soc. Expt. Biol. 81:291-294 (1952).
Chen et al., Biochem. Biophys. Res. Comm. 151(2):844-850 (1988).
Cho et al., J. Nutr. 111:914-922 (1981).
Cook et al., Biochim. et Biophy. Acta 884:207-210 (1986).
Daas et al., Life Sciences 38(14):1305-1308 (1986).
Davis et al., Current Surgery Sep.-Oct. 1988 pp. 392-395.
Dawson et al., Arch. Toxicol. 55:11-15 (1984).
Deneke et al., J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 54(1):147-151 (1983).
Deneke et al., J. Appl. Physiol. 58(2):571-574 (1985).
Galvin et al., Am. J. Physiol. 235(6):H657-H663 (1978).
Griffith et al., Proc. Natl. Acad. Sci. USA 76 (12):6319-6322 (1979).
Griffith et al., Proc. Natl. Acad. Sci. USA 76(11):5606-5610 (1979).
Harlan et al., J. Clin. Invest. 73:706-713 (1984).
Harrison et al., The Lancet 335:1572-1573 (1990).
Hirota et al., Gastroenterology 97:853-859 (1989).
Horejsi et al., Folia Haematol. 86:220-225 (1966).
Izard et al., Mutation Research 47:115-138 (1978).
Keller et al., Arch. Surg. 120:941-945 (1985).
Kern et al., Exp. Eye Res. 17:455-462 (1973).
Kosower, Int. Rev. Cytology 54:109-160 (1978).
Kosugi et al., "New Approaches To Shock Therapy:Reduced Glutathione (GSH(" in Molecular Aspects of Shock and Trauma, pp. 253-269, Alan R. Liss, Inc. (1983).
Lash et al., Proc. Natl. Acad. Sci. USA 83:4641-4645 (1986).
Lauterburg et al., J. Clin. Invest. 67:1415-1424 (1981).
Schulman et al., Annals of Internal Med. 93:330-346 (1980).
Lautersburg et al., Gastroenterology 77(5):A24 (1979).
Lauterburg, et al., Adv. Exp. Med. Biol. 136 (part A):453-461 (1981).
Leaf et al., Biochem. J. 41:280-287 (1947).
Lewis et al., Pharmacology 39:121-128 (1989).
McIntyre et al., Int. J. Biochem. 12:545-551 (1980).
Matthews et al., Immunology 62:153-155 (1987).
Meister et al., Ann. Rev. Biochem. 45:959-604 (1976).
Meister, Nutrition Reviews 42(12):397-409 (1984).
Meister, J. Biol. Chem. 263(33):17205-17208 (1988).
Meredith et al., Brit. Med. J. 293:345-346 (1986).
Ogasawara et al., Res. Exp. Med. 189:195-204 (1989).
Richman et al., J. Biol. Chem. 250(4):1422-1426 (1975).
Roos et al., Agents and Actions 10(6):528-535 (1980).
Strubelt et al., Toxicology and Applied Pharmacology 60:66-77 (1981).
Sumida et al., Jap. Cir. J. 45:1364-1368 (1981).
Szabo et al., Science 214:200-202 (1981).
Szymanski et al.,P.S.E.B.M. 129:966-968 (1968).
Waelsch et al., J. Biol. Chem. 144:53-58 (1942).
Watanabe et al., Immunopharmacology and Immunotoxicology 10(1):109-116 (1988).
Weinberg et al., J. Clin. Invest. 80:1446-1454 (1987).
Welbourne, Can. J. Biochem. 57:233-237 (1979).
Palekar et al., Biochem. Biophys Res. Comm. 62(3):651-657 (1975).
Ballatori et al., Am. J. Physiol. 263:G617-G624 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enhancement of glutathione levels with glutamine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of glutathione levels with glutamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of glutathione levels with glutamine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2191204

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.